Clinical Trial Overview including  different therapeutic areas (TAs), indication and compound  different design with open label, single and double blinding  how and what a study designs and what the rationale to conduct each study phase  when subject enter clinical study, what the study milestones would be  different kinds of molecule types  from sponsor’s perspective, how and what we design a clinical trial and how many resources from internal and external stakeholders would need  best practice sharing